Jonathan McNeill, Chief Business Officer at Dyne Therapeutics, Inc. (DYN), sold 2,705 shares at $45.01 ($122K) on 2024-08-19, disclosed to the SEC on 2024-08-20.
Scheduled sale ($122k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.01 | 2,400 | $108K | 88.5% |
| 2 | $46.00 | 305 | $14K | 11.5% |
| Total | $45.12 avg | 2,705 | $122K | 100% |
| Filing → |
| DYN | SELL | 2024-06-11 | $114K | — | Filing → |
| DYN | SELL | 2024-05-17 | $143K | — | Filing → |
| DYN | SELL | 2024-03-13 | $5.2M | — | Filing → |